OVERALL SURVIVAL AND SEQUENTIAL TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER TREATED BY GERMAN OFFICE-BASED MEDICAL ONCOLOGISTS - OUTCOME DATA FROM THE TMK REGISTRY GROUP

被引：0
|
作者：
Marschner, Norbert [1 ]
Daessler, Klaus-Ulrich [2 ]
Mueller-Hagen, Sigrun [3 ]
Kruggel, Lisa [4 ]
Jaenicke, Martina [4 ]
Tesch, Hans [5 ]
机构：
[1] Praxis Interdisziplinare Onkol & Hamatol, Freiburg, Germany
[2] Onkol Schwerpunktpraxis, Freital, Germany
[3] Hamatoonkol Schwerpunktpraxis, Hamburg, Germany
[4] IOMEDICO, Freiburg, Germany
[5] Onkol Gemeinschaftspraxis, Frankfurt, Germany
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
10.1016/S0960-9776(13)70052-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [1] Overall survival and sequential treatment of patients with metastatic breast cancer treated by German office-based medical oncologists - outcome data from the TMK Registry
    Tesch, H.
    Daessler, K-U
    Mueller-Hagen, S.
    Kruggel, L.
    Jaenicke, M.
    Marschner, N.
    ONKOLOGIE, 2013, 36 : 98 - 98
  • [2] EFFECTIVENESS OF TAXANE- OR ANTHRACYLINE-BASED COMPARED TO TAXANE- AND ANTHRACYLINE-FREE FIRST-LINE TREATMENTS OF PATIENTS WITH METASTATIC BREAST CANCER TREATED BY GERMAN OFFICE-BASED MEDICAL ONCOLOGISTS. DATA FROM THE TMK REGISTRY GROUP
    Marschner, Norbert
    Doerfel, Steffen
    Meyer, Dirk
    Petersen, Volker
    Frank, Melanie
    Jaenicke, Martina
    Tesch, Hans
    BREAST, 2013, 22 : S33 - S33
  • [3] Overall survival of metastatic breast cancer patients - data from the PRAEGNANT breast cancer registry
    Taran, Florin-Andrei
    Fasching, Peter A.
    Volz, Bernhard
    Huober, Jens
    Overkamp, Friedrich
    Kolberg, Hans Christian
    Hadji, Peyman
    Tesch, Hans
    Haeberle, Lothar
    Ettl, Johannes
    Lux, Michael P.
    Hartkopf, Andreas D.
    Lueftner, Diana
    Wallwiener, Markus
    Mueller, Volkmar
    Beckmann, Matthias W.
    Belleville, Erik
    Wimberger, Pauline
    Hielscher, Carsten
    Geberth, Matthias
    Fersis, Nikos
    Abenhardt, Wolfgang
    Kurbacher, Christian
    Wuerstlein, Rachel
    Thomssen, Christoph
    Untch, Michael
    Janni, Wolfgang
    Fehm, Tanja N.
    Wallwiener, Diethelm
    Brucker, Sara Y.
    Schneeweiss, Andreas
    CANCER RESEARCH, 2018, 78 (04)
  • [4] Overall survival and sequential treatment of patients with advanced NSCLC in German outpatients centres - data from the clinical TLK Registry
    Marschner, N.
    Bertram, M.
    von Verschuer, U.
    Kopfmann, S.
    Tessen, H. W.
    ONKOLOGIE, 2013, 36 : 29 - 29
  • [5] First data on overall survival of metastatic breast cancer patients in Austria according to breast cancer subtype: results from the AGMT MBC Registry
    Rinnerthaler, G.
    Gampenrieder, S. P.
    Petzer, A.
    Tinchon, C.
    Fuchs, D.
    Balic, M.
    Heibl, S.
    Rumpold, H.
    Egle, D.
    Zabernigg, A. F.
    Singer, C. F.
    Andel, J.
    Hubalek, M.
    Knauer, M.
    Greil, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 40 - 40
  • [6] EGFR mutation testing and treatment with tyrosin-kinase inhibitors in patients with metastatic non-small cell lung cancer treated by office based medical oncologists in Germany - data from the clinical registry on lung cancer (TLK)
    Bertram, M.
    Petersen, V
    Hessling, J.
    Tessen, H. W.
    Muenz, M.
    Jaenicke, M.
    Spring, L.
    Marschner, N.
    Oncology Research and Treatment, 2015, 38 : 269 - 269
  • [7] Progression-free and overall survival of patients with advanced or metastatic pancreatic cancer in German outpatient centers - first outcome data from the clinical TPK Registry
    Hegewisch-Becker, S.
    Hofheinz, R.
    Wolf, T.
    Aldaoud, A.
    Harde, J.
    Kopfmann, S.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 : 5 - 5
  • [8] Current treatment landscape of advanced triple negative breast cancer patients among a network of office-based oncologists and gynecologists in Germany
    Braun, Michael
    Stoetzer, Oliver J.
    Salat, Christoph
    Borchardt, Jens
    Reichelt, Ralf
    Kuske, Andra
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 25 - 26
  • [9] No Survival Benefit for Patients with Treatment in Certified Breast CentersA Population-based Evaluation of German Cancer Registry Data
    Schrodi, Simone
    Tillack, Anett
    Niedostatek, Antje
    Werner, Carmen
    Schubert-Fritschle, Gabriele
    Engel, Jutta
    BREAST JOURNAL, 2015, 21 (05): : 490 - 500
  • [10] Combination or sequential single agent for the treatment of metastatic breast cancer (MBC) patients (pts). Impact of further chemotherapy (CT) in overall survival (OS) in the Alamo registry
    Lluch, A.
    Ruiz, A.
    Martin, M.
    Alba, E.
    Pastor, M.
    de la Haba, J.
    Llombart, A.
    Ramos, M.
    del Prado, P. Martinez
    Escudero, M. J.
    CANCER RESEARCH, 2009, 69 (02) : 193S - 193S
12345